Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/Amlodipine FDC vs Telmisartan in Hypertension
NCT01222520Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, amlodipine in essential hypertension, sponsored by Boehringer Ingelheim. Started Oct 2010; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01222520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222520.